Skip to content

HEERSE APOTHEEK

Active
Private limited companyfounded 1999active for 27 yearsSteenweg(H.) 129, 3870 Heers, BelgiumKBO/BCE: BE 0466.404.110
Summary

HEERSE APOTHEEK has been active since 1999 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €151,534 and a net result of €43,591. Equity is growing by about 22% per year across the filed financial years. Its solvency ranks better than 20% of 12,672 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Risk analysisFollow ReportCompare
HEERSE APOTHEEKActiveChecked score 70/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
7th largest company by total assets in Heers, Wholesale and retail trade sector1 site
Size
€1.6mtotal assets 2025
Staff
3.6 FTE
Equity
€151,534
Profit
€43,591
Turnover not published (abbreviated format)
Financial health
70 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.6%
Structure
Parent
CHEFAR · 97.62%
Holdings
1
2025 accounts 15 days early3 deeds in the Belgian Official Gazette
Why 70raises riskEquity €151,534 (9.6% of total assets)Sector: Retail trade (NACE 47)lowers riskFounded in 1999Size: 3.6 FTE, total assets €1.6mShow the evidence

Checked score

Score 2025
70 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 39% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Average
Solvency 35+1
equity 9.6% of total assets
Liquidity 37-7
short-term debt 51.6% · cash 10.6%
Profitability 72-4
return on assets 2.8%
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%

About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,231 companies, NACE 47, micro)
Last 24 months 11-2024: 0.7% 12-2024: 0.7%● unchanged vs 11-2024 01-2025: 0.7%● unchanged vs 12-2024 02-2025: 0.7%● unchanged vs 01-2025 03-2025: 0.7%● unchanged vs 02-2025 04-2025: 0.7%● unchanged vs 03-2025 05-2025: 0.7%● unchanged vs 04-2025 06-2025: 0.7%● unchanged vs 05-2025 07-2025: 0.9%▲ +0.2 percentage points vs 06-2025 08-2025: 1.3%▲ +0.4 percentage points vs 07-2025highest value 09-2025: 0.7%▼ -0.6 percentage points vs 08-2025 10-2025: 0.7%● unchanged vs 09-2025 11-2025: 0.7%● unchanged vs 10-2025 12-2025: 0.7%● unchanged vs 11-2025 01-2026: 0.7%● unchanged vs 12-2025 02-2026: 0.7%● unchanged vs 01-2026 03-2026: 0.7%● unchanged vs 02-2026 04-2026: 0.7%● unchanged vs 03-2026 05-2026: 0.7%● unchanged vs 04-2026 06-2026: 0.7%● unchanged vs 05-2026 07-2026: 0.8%▲ +0.1 percentage points vs 06-2026 08-2026: 0.6%▼ -0.2 percentage points vs 07-2026lowest value 09-2026: 0.6%● unchanged vs 08-2026lowest value 10-2026: 0.6%● unchanged vs 09-2026lowest value
Credit of up to €10,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.85, compared with 0.87 in 2024, below 1; short-term debt: 51.6% and cash: 10.6% of total assets), and 90.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 26% on solvency, 35% on liquidity, 56% on profitability and 39% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Equity €151,534 (9.6% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Founded in 1999
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Size: 3.6 FTE, total assets €1.6m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 12672 sector peers (2025).
NBB · sector comparison
Position among 12672 sector peers
Solvency
better than 20%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
15 days early
2024
6 days late
2023
9 days late
2022
57 days late
2021
5 days early
2020
20 days late
2019
26 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 14 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 6 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
25-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Annual accounts filedfinancial year 2023 · abbreviated…

Key points

  • Positive: 7th largest company by total assets in Heers, Wholesale and retail trade…in the Checked rankings No. 7 View
  • Controlled by CHEFARthe company in turn controls 2 companies 97.62% View
  • Positive: 5 profitable years in a rowprofit 2025: €43,591 5 years View

By topic

Financials

Financial year
2025
Total assets
€1.6m
Profit
€43,591
Solvency
9.6%
Total assets▼ 3.8%
Net result
20182025
Go to Financials

Timeline

Events
31
Since
2001
Next accounts
by 31-07-2027
  1. 31-12-2023Equity above €150,000
  2. 28-12-2023General meeting · Other provision
  3. 26-09-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
01-07-1999
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about HEERSE APOTHEEK

What is the company number of HEERSE APOTHEEK?
0466.404.110. In Belgium the VAT number is the company number with BE in front: BE 0466.404.110.
Where is HEERSE APOTHEEK based?
The registered office is at Steenweg(H.) 129, 3870 Heers.Company details
What does HEERSE APOTHEEK do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of HEERSE APOTHEEK?
Private limited company (BV).
When was HEERSE APOTHEEK founded?
On 01-07-1999.
Is HEERSE APOTHEEK still active?
Yes, HEERSE APOTHEEK is an active enterprise in the KBO register.
How many employees does HEERSE APOTHEEK have?
On average 3.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of HEERSE APOTHEEK?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is HEERSE APOTHEEK profitable?
In financial year 2025, HEERSE APOTHEEK made a profit of €43,591.
Where can I find the annual accounts of HEERSE APOTHEEK?
HEERSE APOTHEEK filed 26 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of HEERSE APOTHEEK due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to HEERSE APOTHEEK

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure